Drug Type Live biotherapeutic products |
Synonyms AVT1A4710, SVT1A4710+immunosuppressants |
Target- |
Action modulators |
Mechanism Bacteria replacements, Gastrointestinal microbiome modulators, Microbiome modulators |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colitis, Ulcerative | IND Application | Australia | 01 Jan 2025 | |
Psoriasis | IND Application | Australia | 30 Jan 2022 | |
Rheumatoid Arthritis | IND Application | Australia | 30 Jan 2022 |